Search Results
May 12, 2026, 10:00 ET TIAA and Max Greyserman Team Up to Reach Golf's Next Generation of Investors
his debuts at the Masters Tournament (T32) and PGA Championship (T33). He first gained national attention in 2017 when he qualified for and competed in the U.S. Open as an amateur. He has participated in two more U.S. Opens since, with finishes of T21 in 2024 and T23 in 2025. About
More news about: TIAA
May 12, 2026, 10:00 ET FirstComm Announces Mike Bee as Vice President of Sales
achieved measurable results in a highly competitive market. Prior to joining Verve in 2015, Bee held senior sales roles at Cox Business, AT&T, and CenturyLink (formerly TW Telecom). Throughout his career, he has established a strong track record of exceeding targets, cultivating long-term
More news about: FirstComm
May 12, 2026, 10:00 ET Cizzle Bio CEO Bill Behnke Participates in National Oncology Commercialization Panel at City of Hope's 25th Ci4CC Summit
Larry Kwak, MD, PhD, who serves as CEO and chief scientific officer of PreproMene Bio, a biotechnology company advancing novel treatments including CAR-T cell and targeted antibody therapies, and Rick Heinick, CEO of SLAM BioTherapeutics, a company focused on developing targeted oncology therapies that
More news about: Cizzle Bio
May 12, 2026, 09:53 ET Enliven Therapeutics Announces Oral Presentation at the EHA 2026 Congress Featuring Additional Positive Phase 1 Clinical Trial Data for ELVN-001 in CML
evaluate safety and tolerability and to determine the recommended dose for further clinical evaluation of ELVN-001 in patients with CML with and without T315I mutations that is relapsed, refractory or intolerant to TKIs. Secondary endpoints include pharmacokinetics, MMR by central quantitative reverse transcriptase
More news about: Enliven Therapeutics, Inc.
May 12, 2026, 09:45 ET Breakthrough T1D Southern Ohio Chapter Hosts 42nd Annual Cincinnatian of the Year Gala, Raising Over $1 Million
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, gathered guests on Saturday, May 9, 2026, for the annual Cincinnatian of the Year Gala to raise critical funds for research focused on curing, preventing, and treating T1D. Hosted by Breakthrough T1D Southern
More news about: Breakthrough T1D, Formerly JDRF
May 12, 2026, 09:30 ET Lung Cancer Research Foundation Grants Team Science Award Focused on Understanding and Treating Lung Cancers with HER2 Mutations
The second project will comprehensively characterize the landscape of HER2-independent resistance to HER2 TKIs and develop novel cellular therapies and T-cell engagers against drug-tolerant persister cells (DTPCs) and drug resistance cells (DRCs). This will identify candidate therapeutic targets and test
More news about: Lung Cancer Research Foundation
May 12, 2026, 09:27 ET Eggland's Best Cracks into FOX's MasterChef Season 16
Officer, Cathy Payne.About Tiffany DerryBeaumont native Tiffany Derry is the founder of Tiffany Derry Concepts and co-founder of T2D Concepts, the Texas-based purpose-driven hospitality group behind Roots Southern Table, Radici Wood-Fired Grill, Roots Chicken Shak, The Landing, Syrup
More news about: Eggland's Best
May 12, 2026, 09:05 ET The Yukon's Capital Cycle Has Turned -- and This 18-Project Junior Is Quietly Building the Next District-Scale Story
intersected 47.4 metres of 0.43 g/t gold from 26.6 metres depth, including a high-grade core of 1.0 metre at 14.35 g/t gold at 71 metres [6]. The release also reported a deeper, second skarn horizon in the same hole returning 33.8 metres of 0.19 g/t gold from 278.7 metres, supporting
More news about: Equity Insider
May 12, 2026, 09:00 ET T-Mobile 5G Advanced network achieves world first with Ericsson AI RAN innovation
real-time performance gains that enhance user experience while helping operators like T-Mobile maximize the value of their spectrum."This work demonstrates the power of AI-native RAN capabilities. Ericsson and T-Mobile will continue to collaborate to identify new opportunities where AI can drive
More news about: Ericsson
May 12, 2026, 09:00 ET RITUAL ZERO PROOF EXPANDS INTO READY-TO-DRINK WITH NEW LINE OF PREMIUM NON-ALCOHOLIC COCKTAILS
Ritual Zero Proof enters the ready-to-drink (RTD) category with three canned non-alcoholic cocktails: Margarita, G&T, and SpritzEach expression is inspired by Ritual's award-winning zero-proof spirits including Agave Spirit Alternative, Gin Alternative, and Aperitif
More news about: Diageo North America
May 12, 2026, 09:00 ET Porton Advanced Stem Cell Exosomes Granted INCI Status, Advancing into Global Cosmetic Ingredient Market
CRO and CDMO platforms focusing on plasmids, viral vectors (lentiviral vector, adenoviral vector, AAV,etc), cell therapy CMC services including CAR-T, TCR-T, CAR-NK, HSC, exosome, etc) and nucleic acid therapies. Our state-of-the-art, GMP-compliant facilities span an impressive 215,000 sq ft, equipped
More news about: Porton Advanced
May 12, 2026, 09:00 ET Circet Announces Evolution of U.S. Executive Leadership and Appointment of Bill Hogg as CEO of Circet USA
Chief Executive Officer of Gigapower LLC, an AT&T and BlackRock joint venture, where he built one of the largest open‑access fiber‑to‑the‑home platforms in the United States from the ground up. Prior to Gigapower, he held senior leadership roles at AT&T Inc. spanning global technology operations,
More news about: Circet USA
May 12, 2026, 08:42 ET Zackat Labs, AT&T Business and RCW Energy Services Unveil Innovative Connected Safety Platform with Wearable Heat Stress and Gas Monitoring Solution
solutions.About AT&T Business: AT&T Business offers a wide range of solutions designed to meet the needs of companies of all sizes. Our services include high-speed internet, robust networking, mobile connectivity, cybersecurity, cloud services, and IoT solutions. AT&T Business also provides
More news about: Zackat Labs, Inc.
May 12, 2026, 08:30 ET T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR APRIL 2026
BALTIMORE, May 12, 2026 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced April month-end assets under management of $1.83 trillion. Net outflows for April 2026 were $10.6 billion driven by a few large redemptions
More news about: T. Rowe Price Group
May 12, 2026, 08:30 ET Bubble Skincare and American Eagle Come Together to Celebrate the Power of Community, Comfort and Everyday Rituals
including but not limited to:EXCLUSIVE AE x Bubble Boxy Graphic T-Shirt (Mint), $34.95EXCLUSIVE AE x Bubble Fleece Hoodie (Lavender), $64.95AE x Bubble Boxy Graphic T-Shirt, $34.95AE x Bubble Fleece Hoodie (available in Chalk, Blooming Bright Blue &
More news about: Bubble Beauty Inc.
May 12, 2026, 08:03 ET Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
NextCure, Inc., overseeing first-in-human and proof-of-concept oncology trials, and Chief Medical Officer of NexImmune, Inc., a clinical-stage developer of T cell–based immunotherapies.Earlier in his industry career, Dr. Myint held senior leadership roles at Celgene Corporation (now part of Bristol Myers
More news about: Halia Therapeutics
May 12, 2026, 07:30 ET TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
drug conjugates (ADCs) targeting Myeloid Derived Suppressor Cells to inhibit their immune-suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies.For more information, please visit
More news about: TuHURA Biosciences, Inc.
May 12, 2026, 07:05 ET Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026
baseline BMI ≥30 kg/m2 or BMI≥27 kg/m2 with at least one weight-related comorbid condition. 4) Least squares mean. 5) Two-sided t-test using mixed model for repeated measures. 6) Logistic regression model with treatment as factor and baseline weight as covariate.Poster
More news about: Viking Therapeutics, Inc.
May 12, 2026, 07:02 ET 1911 Gold Confirms Extensions of the L10 Zone at True North Intersecting 11.54 g/t Gold over 3.70 m
of 363,000 tonnes ("t") at 4.99 g/t Au for 67,000 ounces ("oz") and an inferred resource of 479,000 t at 3.96 g/t Au for 61,000 oz. 710-711 hosts a current indicated resource of 1,182,000 t at 5.21 g/t Au for 198,000 oz and an inferred resource of 938,000 t at 3.91 g/t Au for 118,000 oz.
More news about: 1911 Gold Corporation
May 12, 2026, 07:00 ET OceanaGold Announces Additional High-Grade Drill Results at Haile
15.5 m @ 30.64 g/t Au (UGD0121)30.5 m @ 13.86 g/t Au (UGD0113)22.5 m @ 13.42 g/t Au (UGD0122)18.4 m @ 9.62 g/t Au (UGD0119)21.9 m @ 6.48 g/t Au including 3.7 m @ 23.55 g/t Au (UGD0120)26.3 m @ 3.41 g/t Au and 44.3 m @
More news about: OceanaGold Corporation
May 12, 2026, 07:00 ET OceanaGold Announces Additional High-Grade Drill Results at Haile
15.5 m @ 30.64 g/t Au (UGD0121)30.5 m @ 13.86 g/t Au (UGD0113)22.5 m @ 13.42 g/t Au (UGD0122)18.4 m @ 9.62 g/t Au (UGD0119)21.9 m @ 6.48 g/t Au including 3.7 m @ 23.55 g/t Au (UGD0120)26.3 m @ 3.41 g/t Au and 44.3 m @
More news about: OceanaGold Corporation
May 12, 2026, 07:00 ET Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
inflammatory pathways linked to AD. Advanced analytics translate this biology into two results: a Janus kinase (JAK) Inhibitor Responder Profile or a T-helper 2 (Th2) Molecular Profile, providing clear, actionable guidance at the therapy-class level. AdvanceAD-Tx allows clinicians to match therapy to
More news about: Castle Biosciences, Inc.
May 12, 2026, 07:00 ET CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
that in normal human peripheral blood mononuclear cells (PBMCs) in a T-cell activation model, store-operated calcium entry (SOCE) blockers such as Auxora inhibit the expression of pro-inflammatory and cytotoxic genes within regulatory T cells, while crucially preserving tolerance-associated anti-inflammatory
More news about: CalciMedica, Inc.
May 12, 2026, 07:00 ET Brainomix and Boehringer Ingelheim Advance Strategic Partnership in Pulmonary Fibrosis
Wyrtzen, Chief Marketing [email protected]T +44 (0)1865 582730Media EnquiriesUSAJordyn TemperatoLifeSci Communications
More news about: Brainomix